Liposome/bronchodilator method & System
August 23, 2011. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent References 3322625 3594476 Azapurinones Treatment of human viral diseases with 1-B-D-ribofuranosyl-1,2,4-triazole-3-carboxamide Procedures and pharmaceutical products for use in the administration of antihistamines Method of encapsulating biologically active materials in lipid vesicles Process and device for producing bilayer vesicles Process for preparing lipid vesicles by vaporisation of solvents Arachidonic acid analogues, processes for their preparation and their use in medicine Patent #: 4699995 InventorsAssigneeApplicationNo. 366299 filed on 06/13/1989US Classes:424/450, Liposomes424/45, Organic pressurized fluid514/826, ASTHMA514/930, VASOCONSTRICTOR (NONDECONGESTANT)514/958FOR SMOKING OR INHALINGExaminersPrimary: Lovering, Richard D.Attorney, Agent or FirmForeign Patent References
International ClassesA61K 009/127A61K 009/42 AbstractA method and system for treating bronchial constriction. The system includes a liposome composition containing a 댢 -adrenoreceptor agonist in a liposome-entrapped form, and a device for aerosolizing a metered quantity of the composition. The drug in liposome aerosol form is substantially more effective in bronchodilation, over a substantially longer time, than the same amount of drug in free-drug aerosol form. | |
